- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT01072396
Effects of Tiotropium on Breathing Capacity and Exercise Limitation in Early Stages of Chronic Obstructive Pulmonary Disease
A Randomized, Double-blind, Placebo-controlled, 6-week, Crossover Study to Examine the Effects of Tiotropium (Spiriva® HandiHaler®, 18 µg Once Daily) on Dynamic Hyperinflation and Physical Exercise Capacity in Patients With Early Stage Chronic Obstructive Pulmonary Disease (COPD)
연구 개요
연구 유형
등록 (실제)
단계
- 4단계
연락처 및 위치
연구 장소
-
-
Alabama
-
Birmingham, Alabama, 미국
- 205.440.1006 Boehringer Ingelheim Investigational Site
-
Jasper, Alabama, 미국
- 205.440.1015 Boehringer Ingelheim Investigational Site
-
-
California
-
Torrance, California, 미국
- 205.440.1002 Boehringer Ingelheim Investigational Site
-
-
Connecticut
-
Hartford, Connecticut, 미국
- 205.440.1018 Boehringer Ingelheim Investigational Site
-
-
Illinois
-
Springfield, Illinois, 미국
- 205.440.1008 Boehringer Ingelheim Investigational Site
-
-
Indiana
-
Muncie, Indiana, 미국
- 205.440.1017 Boehringer Ingelheim Investigational Site
-
-
Michigan
-
Livonia, Michigan, 미국
- 205.440.1020 Boehringer Ingelheim Investigational Site
-
-
New Hampshire
-
Lebanon, New Hampshire, 미국
- 205.440.1011 Boehringer Ingelheim Investigational Site
-
-
North Carolina
-
Charlotte, North Carolina, 미국
- 205.440.1019 Boehringer Ingelheim Investigational Site
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, 미국
- 205.440.1013 Boehringer Ingelheim Investigational Site
-
-
South Carolina
-
Spartanburg, South Carolina, 미국
- 205.440.1007 Boehringer Ingelheim Investigational Site
-
-
-
-
Ontario
-
Kingston, Ontario, 캐나다
- 205.440.2003 Boehringer Ingelheim Investigational Site
-
-
Quebec
-
Montreal, Quebec, 캐나다
- 205.440.2001 Boehringer Ingelheim Investigational Site
-
Montreal, Quebec, 캐나다
- 205.440.2004 Boehringer Ingelheim Investigational Site
-
Ste-Foy, Quebec, 캐나다
- 205.440.2002 Boehringer Ingelheim Investigational Site
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion criteria:
For COPD subjects: Male or female, age of 40 years or older, smoking history >10 pack-years, symptomatic defined as baseline dyspnea index focal score of 9 or more and / or daily cough with production of sputum for three months per year during at least two consecutive years, diagnosis of early stage COPD according to: post-bronchodilator FEV1/FVC ratio <70%., FEV1 >/=50% post-bronchodilator predicted normal, and a decreased Inspiratory Capacity during exercise. For Age / Gender Matched Controls: Male or female, age of 40 years or older, nonsmoker, with no significant diseases.
Exclusion criteria:
Patients with a significant disease other than COPD; a significant disease is defined as a disease which, in the opinion of the investigator, may (i) put the patient at risk because of participation in the study, (ii) influence the results of the study, or (iii) cause concern regarding the patient's ability to participate in the study.
Patients with a history of asthma, Patients requiring the use of supplemental oxygen therapy, Patients who have a limitation of exercise performance as a result of factors other than fatigue or exertional dyspnoea, such as arthritis in the leg, angina pectoris, claudication or other conditions, or Patients with contraindications to exercise.
Note: Additional exclusion criteria for Age / Gender Matched Controls: Patients with a significant disease including COPD.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 크로스오버 할당
- 마스킹: 더블
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
활성 비교기: 18 mcg tiotropium
Patient to receive 1 tiotropium bromide inhalation powder capsule daily (in the morning) via HandiHaler
|
double blind randomized crossover
|
위약 비교기: Placebo
Patient to receive 1 placebo inhalation powder capsule daily (in the morning) identical to those containing tiotropium bromide inhalation powder via HandiHaler
|
inhalation powder capsule identical to those containing tiotropium bromide inhalation powder
|
간섭 없음: Control
Age and gender matched control subjects to conduct incremental and constant work rate exercise tests for comparison to subjects with early stage COPD
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Change From Baseline in Inspiratory Capacity (IC) at Isotime
기간: baseline, six weeks of treatment
|
Inspiratory capacity (IC) during CWR exercise testing measured at isotime (isotime was established during CWR exercise testing at baseline).
Isotime is the minimum exercise time among all tests.
Constant work rate exercise means the exercise is done under constant work rate.
|
baseline, six weeks of treatment
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Constant Work Rate (CWR) Endurance Time
기간: six weeks of treatment
|
CWR exercise duration calculated as the length of time of the exercise period
|
six weeks of treatment
|
Change From Baseline in Modified Borg Scale Ratings for Dyspnea Intensity at Isotime
기간: baseline, six weeks of treatment
|
Modified Borg Scale is a participant rating of the intensity of dyspnea measured on a scale ranging from 0 (Nothing at all) to 10 (Maximal, most severe ever experienced).
|
baseline, six weeks of treatment
|
공동 작업자 및 조사자
협력자
간행물 및 유용한 링크
일반 간행물
- Gagnon P, Casaburi R, Saey D, Porszasz J, Provencher S, Milot J, Bourbeau J, O'Donnell DE, Maltais F. Cluster Analysis in Patients with GOLD 1 Chronic Obstructive Pulmonary Disease. PLoS One. 2015 Apr 23;10(4):e0123626. doi: 10.1371/journal.pone.0123626. eCollection 2015.
- Porszasz J, Blonshine S, Cao R, Paden HA, Casaburi R, Rossiter HB. Biological quality control for cardiopulmonary exercise testing in multicenter clinical trials. BMC Pulm Med. 2016 Jan 16;16:13. doi: 10.1186/s12890-016-0174-8.
- Casaburi R, Maltais F, Porszasz J, Albers F, Deng Q, Iqbal A, Paden HA, O'Donnell DE; 205.440 Investigators. Effects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014 Nov;11(9):1351-61. doi: 10.1513/AnnalsATS.201404-174OC.
- O'Donnell DE, Maltais F, Porszasz J, Webb KA, Albers FC, Deng Q, Iqbal A, Paden HA, Casaburi R; 205.440 investigators. The continuum of physiological impairment during treadmill walking in patients with mild-to-moderate COPD: patient characterization phase of a randomized clinical trial. PLoS One. 2014 May 1;9(5):e96574. doi: 10.1371/journal.pone.0096574. eCollection 2014.
유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- 205.440
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
Tiotropium에 대한 임상 시험
-
Orion Corporation, Orion Pharma완전한
-
Guangzhou Institute of Respiratory DiseaseBoehringer Ingelheim모병
-
Xiromed LLCLaboratorios Liconsa; Exeltis완전한
-
Neutec Ar-Ge San ve Tic A.Ş완전한
-
Boehringer Ingelheim종료됨